Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT07483723

Glucose Profiles in Women With Polycystic Ovary Syndrome

Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-03-19

80

Participants Needed

1

Research Sites

77 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.

CONDITIONS

Official Title

Glucose Profiles in Women With Polycystic Ovary Syndrome

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age > 18 years at inclusion
  • Diagnosed with polycystic ovary syndrome by at least 2 of 3: irregular menstrual cycles, clinical or biological signs of high androgen levels, polycystic ovary appearance on pelvic ultrasound or elevated AMH levels
  • Agreed to carry the Free-style Libre Pro sensor
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding
  • Presence of other conditions such as hyperprolactinemia, thyroid disorders, Cushing's syndrome, congenital adrenal hyperplasia, virilizing ovarian or adrenal tumor, or taking exogenous androgens
  • Pre-existing diabetes
  • Use of estrogen-progestin contraception, progestin contraception, antidiabetic drugs, inositol, or antiandrogen treatment within 3 months before inclusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHRU Amiens

Salouël, France

Actively Recruiting

Loading map...

Research Team

A

Abdallah Al-Salameh, Pr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here